CLINICAL_TRIALS
research
· 2025-04-15
Clinical Trial Update: Apomorphine in Severe Brain-injured Patients [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical trial update describing apomorphine in patients with severe brain injury and disorder of consciousness, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Liege | Conditions: Disorder of Consciousness | Phase 2, Phase 3 | Status: RECRUITING